Loading...

Drugs Made In America Acquisition Corp. Units

DMAAU•NASDAQ
Financial Services
Financial - Conglomerates
$10.74
$0.24(2.27%)

Drugs Made In America Acquisition Corp. Units (DMAAU) Company Profile & Overview

Explore Drugs Made In America Acquisition Corp. Units’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Drugs Made In America Acquisition Corp. Units (DMAAU) Company Profile & Overview

Drugs Made In America Acquisition Corp. is a blank check company. It is an exempt company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.

SectorFinancial Services
IndustryFinancial - Conglomerates
CEOLynn Stockwell

Contact Information

https://dmaacorp.com
(954) 870-3099
1 East Broward Boulevard, Suite 700​, Fort Lauderdale, FL, 33301

Company Facts

2 Employees
IPO DateJan 27, 2025
CountryUS
Actively Trading

Frequently Asked Questions

;